PCSK6 and familial pancreatic carcinoma: PCSK6 is upregulated in pancreatic cancer liver metastases, and its inactivation results in the decreased migratory potential of tumour cells in pancreatic cancer and reprogramming of cell‒cell junctions (He et al., 2022).